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Abstract
Background: Porcine circovirus type 1 (PCV1) has been described as a non-cytopathic contaminant of the PK-15
cell line. Several experimental infections with PCV1 failed to reproduce disease in pigs. Therefore, PCV1 is generally
accepted as non-pathogenic to pigs. To our knowledge, nothing is known about the outcome of PCV1 infections
in porcine foetuses. This was examined in the present study.
Results: Nine foetuses from three sows were inoculated at 55 days of gestation: three with 104.3 TCID50 of the
PCV1 cell culture strain ATCC-CCL33, three with 104.3 TCID50 of the PCV1 field strain 3384 and three with cell
culture medium (mock-inoculated). At 21 days post-inoculation, all 6 PCV1-inoculated and all 3 mock-inoculated
foetuses had a normal external appearance. Microscopic lesions characterized by severe haemorrhages were
observed in the lungs of two foetuses inoculated with CCL33. High PCV1 titres (up to 104.7 TCID50/g tissue) were
found in the lungs of the CCL33-inoculated foetuses. All other organs of the CCL33-inoculated foetuses and all the
organs of the 3384-inoculated foetuses were negative (< 101.7 TCID50/g tissue) by virus titration. PCV1-positive cells
(up to 121 cells/10 mm2 in CCL33-inoculated foetuses and up to 13 cells/10 mm2 in 3384-inoculated foetuses)
were found in the heart, lungs, spleen, liver, thymus and tonsils. PCR and DNA sequencing of Rep recovered CCL33
or 3384 sequences from CCL33- or 3384-inoculated foetuses, respectively.
Conclusions: From this study, it can be concluded that cell culture PCV1 can replicate efficiently and produce
pathology in the lungs of porcine foetuses inoculated at 55 days of foetal life.
Background
Porcine circovirus type 1 (PCV1) is a small, non-envel-
oped circular single-stranded DNA virus of the family
Circoviridae. PCV1 was originally detected as a non-
cytopathic contaminant of the PK-15 cell line, ATCC-
CCL33 [1]. PCV1 infections are widely distributed
around the world as described before [2-4]. Seropreva-
lence of PCV1 at herd level varies between 10% [5] and
100% [6]. Although PCV1 DNA has been isolated from
lymph nodes of a piglet in France with a wasting condi-
tion [7], it is generally accepted that PCV1 is non-patho-
genic to pigs [8-13]. Experimental infections with PCV1
failed to reproduce disease in pigs [8,9,14]. The distribu-
tion of PCV1 in different pig tissues after experimental
infections has been demonstrated [9]. PCV1 has been
detected in cases of congenital tremors in newborn pigs
and aborted/stillborn piglets, indicating the possible
occurrence of vertical transmission of PCV1 [9,15-17].
In contrast, no evidence of PCV1 infection was found in
piglets affected with congenital tremors in an 11 years
retro-prospective study [18]. To our knowledge, nothing
is known about the outcome of PCV1 infections in por-
cine foetuses.
In the present study, the virological and pathological
outcomes were examined in porcine foetuses that were
experimentally inoculated with PCV1 at 55 days of
gestation.
Methods
Viruses
Two different PCV1 strains were used in this study. The
PCV1 cell culture strain CCL33, was originally detected
as a non-cytopathic contaminant of the PK-15 cell line
[1,19]. The PCV1 field strain 3384 was isolated from
stillborn piglets [9]. Both PCV1 strains have been
sequenced and their full genomic sequences have been
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deposited in GenBank [GenBank: JN133302 and
JN133303].
Experimental design
Due to the high seroprevalence of PCV1 in Flemish
sows [6], viral replication and pathology cannot be stu-
died by (oro)nasal inoculation of sows during gestation
or by intrauterine inoculation of sows at insemination.
Therefore, experimental PCV1 infections in foetuses
have to be performed by direct in utero inoculation.
Three conventional PCV1 seropositive Landrace sows
were submitted to laparatomy at 55 days of gestation.
Laparotomy of the sows was performed under anaesthe-
sia as described previously [20]. In each of the three
sows, three foetuses were inoculated: one foetus with
the PCV1 cell culture strain CCL33; one with the PCV1
field isolate 3384 and one foetus with cell culture med-
ium. The position in the uterus of the PCV1- and
mock-inoculated foetuses, and their adjacent foetuses, is
shown in Table 1. The inoculations were performed as
described previously [20]. Briefly, the foetuses were
inoculated by trans-uterine injection with 200 μL, con-
taining 104.3 TCID50 of PCV1, into the peritoneal (100
μL) and amniotic (100 μL) cavities. For mock-inoculated
foetuses, PK-15 cell culture medium (200 μL) was
inoculated by trans-uterine injection with 200 μL into
the peritoneal (100 μL) and amniotic (100 μL) cavities.
The inoculated foetuses were marked with a synthetic,
non-absorbable, superficial suture (Prolene® 2-0, Ethi-
con, Inc., Somerville, New Jersey, U.S.A.) on the exterior
uterine wall. Antibiotics were administered to the sows
before closure of the operation wound (Duphapen®
Strep, (Fort Dodge Animal Health Benelux, Nether-
lands), 10 mL intraperitoneally and 10 mL in the opera-
tion wound).
The sows were housed individually in A2 experimental
units. The sows were observed daily for clinical signs
and their rectal temperature was monitored daily during
the first week after surgery. Twenty-one days post
inoculation (dpi), the sows were humanly euthanized
with an overdose of pentobarbitalum natricum
[Natriumpentobarbital 20%® 40 mg/kg iv in the V. jugu-
laris externa] (Kela Laboratoria, Hoogstraten, Belgium).
Hysterectomy was performed and all foetuses were col-
lected. The specific length of the tail ends of the sutures
was used to determine the PCV1 strain the foetus was
inoculated with.
All inoculated and non-inoculated foetuses were
examined for gross lesions and tissue samples were col-
lected from the heart, lungs, spleen, liver, kidneys, thy-
mus, tonsils, ileum and cerebrum for histopathological
examinations (haematoxylin and eosin staining), for
virus titrations and for staining of infected cells by indir-
ect immunofluorescence. Serum and abdominal fluid
were collected as well. The serum samples of the sows
were collected prior to surgery (pre-serum) and at the
time of euthanasia (post-serum).
The animal experiments described in this study were
authorized and supervised by the Ethical and Animal
Welfare Committee of the Faculty of Veterinary Medi-
cine of Ghent University.
PCV1 isolation and titrations
Ten% (wt/vol) tissue suspensions (spleen, thymus, ton-
sils, ileum) and 20% (wt/vol) tissue suspensions (heart,
lungs, liver, kidneys and cerebrum) were prepared in
phosphate-buffered saline (PBS). For the PCV1-inocu-
lated foetuses, the PCV1 titres in the above mentioned
organs were determined by virus titration in PK-15 cells,
as described before for PCV2 titration [20,21]. Briefly,
PCV1-infected PK-15 cells were revealed by immuno-
peroxidase staining with using an optimal dilution of
mono-specific anti-PCV1 swine polyclonal serum (pro-
duced in our laboratory) and peroxidase-labelled goat-
anti-swine IgG (Jackson ImmunoReasearch, UK) as pri-
mary and secondary antibodies, respectively. For the
mock-inoculated and non-inoculated foetuses, PCV1
titres were determined in the heart, lungs and spleen.
Table 1 PCV1- and mock-inoculated and their adjacent
foetuses and results of PCR.
Sow no. Foetus no.a Inoculated with PCR resultf
S1 L5 NIb -
L6c Mock -
R1 CCL33 +
R2 NIb -
R3 NIb -
R4 3384 +
R5c NIb -
S2 L1 Mock -
L2d NIb -
R1 NIb -
R2 CCL33 +
R3 3384 +
R4d NIb -
S3 L1e Mock -
R1 CCL33 +
R2 3384 +
R3e NIb -
a Foetuses were identified by their position in the uterus. L = left horn; R =
right horn.
Numbering is in sequence from ovary to cervix.
b NI = not inoculated.
c L6 and R5 were adjacent to each other.
d L2 and R4 were adjacent to each other.
e L1 and R3 were adjacent to each other.
f PCR amplification of the Rep gene.
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The titration experiments were repeated independently
for 3 times. For 10% suspensions, the detection limit of
this technique was 102.0 TCID50/g tissue and for 20%
suspensions, the detection limit was 101.7 TCID50/g
tissue.
Single immunofluorescence staining
The number of PCV1-positive cells in all of the col-
lected organs of PCV1-inoculated foetuses and in the
lungs of mock-inoculated and non-inoculated foetuses
was determined by an indirect immunofluorescence
staining (IIF), adapted from the technique described by
Sanchez et al. [21]. Methanol-fixed cryostat sections
were incubated with an optimal dilution of biotin-conju-
gated porcine anti-PCV1 polyclonal antibodies (pAbs).
Subsequently, a 1:200 dilution of fluorescein isothiocya-
nate (FITC)-labelled streptavidin (Molecular Probes,
Eugene, Oregon, USA) in PBS was applied. Both incuba-
tions were performed for 1 h at 37°C and sections were
washed three times with PBS between the incubations.
Finally, sections were incubated with Hoechst (Molecu-
lar Probes, Eugene, Oregon, USA) for 10 min followed
by three washings with PBS. The specificity of the stain-
ing was confirmed by the deletion of primary antibody
(anti-PCV1 pAb) and by the complete absence of fluor-
escence in the tissue sections of non-inoculated, age-
matched foetuses. Stained tissue sections were mounted
with a glycerol solution containing 1,4-diazobicyclo-
2.2.2-octane (DABCO) anti-fading agent (Janssen Chi-
mica, Beerse, Belgium). The number of PCV1-positive
cells was determined in an area of 10 mm2 of tissue by
a LEICA DM/RBE fluorescence microscope (Leica
Microsystems GmbH, Heidelberg, Germany) as
described by Sanchez et al. [21]. Representative digital
images of the stained tissue sections were made using
the Olympus IX81 microscope connected with a Cell-M
Live-Cell imaging module.
Double immunofluorescence staining
To our knowledge, the target cells of PCV1 have not
been characterized with cell markers yet. A cytokeratin
marker monoclonal antibody (mAb) AE1/AE3 (Neomar-
kers, Fremont, CA) was used to identify epithelial cells
[22]. Polyclonal rabbit antibodies against the human
Von Willebrand Factor (pAb anti-human VWF) (Dako-
Cytomation) were used to detect endothelial cells. Since
PCV1 has previously been associated with cells showing
macrophage morphology in pigs [9], the macrophage-
marker mAb 41D3, detecting porcine sialoadhesin, was
used [23,24]. Since mAb 41D3 is specific for macro-
phages, a mAb 74.22.15 (directed against SWC3) was
used which detects not only macrophages but also
monocytes, dendritic cells and granulocytes [25,26].
MAb 28.4.1 directed against IgM [27] was used as
marker for B-lymphocytes. MAbs BB23-8E6 [28],
74.12.4 [29,30] and 76.2.11 [30-32] directed against
CD3, CD4 and CD8, respectively, were used as markers
for T-lymphocytes.
A double immunofluorescence staining for epithelial
cells/endothelial cells/macrophages/B-lymphocytes/T-
lymphocytes and PCV1 was performed in the lungs of
PCV1-inoculated foetuses, adapted from the technique
described by Sanchez et al. [26,33]. Briefly, methanol-
fixed cryostat sections were first incubated with mAb
AE1/AE3 (1:100), pAb VWF (1:25), mAb 41D3 (1:5),
mAb anti-SWC3 (1:10), mAb anti-IgM (1:50), mAb
anti-CD3 (1:50), mAb anti-CD4 (1:50) or mAb anti-CD8
(1:50) and then with FITC-labelled goat-anti-mouse IgG
(1:200) (Molecular Probes, Eugene, Oregon, USA) or
FITC-labelled goat-anti-rabbit IgG (1:200) (Molecular
Probes). Afterwards, the sections were stained for PCV1
antigens by incubation with an optimal dilution of bio-
tin-conjugated porcine anti-PCV1 pAbs. Subsequently, a
1:200 dilution of Texas Red-labelled streptavidin (Mole-
cular Probes) in PBS was added. All antibodies were
diluted in PBS and all incubations were performed for 1
h at 37°C. The sections were washed three times with
PBS after each incubation with primary and secondary
antibodies. Specificity of the staining for different cell
markers (except for the endothelial marker) was demon-
strated using an irrelevant, isotype matched mAb 1C11,
3H12 and 13D12 [34] and by the deletion of primary
antibodies (pAb anti-human VWF and anti-PCV1 pAb),
and by the complete absence of PCV1-specific fluores-
cence in tissue sections of non-inoculated, age-matched
foetuses. The stained tissue sections were mounted as
described above and PCV1-positive cells and double
positive cells (cell marker and PCV1-positive cells) were
quantitated as described previously [26,33] by using a
LEICA DM/RBE fluorescence microscope (Leica Micro-
systems GmbH, Heidelberg, Germany). Representative
digital images of stained preparations were made using
the Olympus IX81 microscope connected with a Cell-M
Live-Cell imaging module.
Amplification of the PCV1 rep gene and sequencing
DNA was extracted from the heart and lung tissues of
PCV1-inoculated, mock-inoculated and their adjacent
foetuses by using a NucleospinR tissue kit (Macherey-
Nagel). A set of primers (PF2: 5’-TTGCTGAGCC-
TAGCGACACC-3’; PR2: 5’-TCCACTGCTTCAAAT
CGGCC-3’) was used to amplify a PCV1 349 bp repli-
case gene (Rep) fragment following the same methods
as described by Larochelle et al. [35]. PCR products
(Rep) were treated with Exonuclease I and Antarctic
Phosphatase (New England Biolabs, Ipswich, USA) and
used directly for cycle sequencing with a Big Dye Ter-
minator Cycle sequencing kit V1.1 (Applied Biosystems,
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Foster City, USA). The cycle sequencing reaction pro-
ducts were purified using ethanol precipitation and
separated on an ABI Genetic Analyzer 310 (Applied
Biosystems, Foster City, USA). Sequence alignments
were performed using bl2seq at http://blast.ncbi.nlm.nih.
gov. To confirm the absence of porcine circovirus type
2 (PCV2) in PCV1-inoculated foetuses, amplification of
PCV2 capsid was performed with the heart and lung tis-
sues as described previously in Saha et al. [20].
Serology
The PCV1-specific antibody titres in serum were deter-
mined by an immuno-peroxidase monolayer assay
(IPMA) as described previously [6]. The PCV1 cell cul-
ture strain CCL33 was used as antigen. The foetuses
were also checked for PCV2-specific antibodies by
IPMA as described above but with PCV2 strain 1121
[36] as antigen. These assays were independently
repeated 3 times.
The sow antibody titres against PCV1, PCV2 and por-
cine reproductive and respiratory syndrome virus
(PRRSV) were determined by an IPMA (as described
above) and the sow antibody titres against porcine par-
vovirus (PPV) were determined by a haemagglutination
inhibition (HI) test as described elsewhere [37,38].
Results
Evaluation of the sows
The three sows were clinically healthy during the whole
study period. No rise of rectal temperature was noticed
in any of the three sows. The operation wounds were
slightly swollen until 48 hours after the operations and
somewhat painful at palpation. The PCV1- and PCV2-
specific IPMA Ab titres of the three sows ranged from
40 to 640 and from 20,480 to 163,840, respectively in
pre-serum and were identical in post-serum. The
PRRSV-specific IPMA Ab titres and PPV-specific HI Ab
titres in the pre-serum ranged from < 10 to 640 and
from < 8 to 512, respectively. Seroconversion against
PRRSV and PPV was not observed in any of the three
sows.
Gross examinations
All PCV1-inoculated foetuses were normal in appear-
ance and no evidence of gross pathological lesions was
observed in any of the PCV1-inoculated foetuses (Figure
1a). The mock-inoculated and non-inoculated foetuses
were also normal in appearance and no gross pathology
was observed.
Microscopic examinations
A haematoxylin and eosin (HE) staining was performed
for different organs (heart, lungs, spleen, liver, kidney,
thymus, cerebrum) of PCV1-inoculated and mock-
inoculated foetuses. Microscopic lesions including severe
haemorrhages in the interlobular regions were observed
in the lung tissue of two foetuses (S1R1 and S2R2)
inoculated with the cell culture PCV1 strain, CCL33
(Figure 1b). Microscopic lesions were not present in the
other organs of these two foetuses. Microscopic lesions
could not be observed in the third CCL33-inoculated
foetus, the three 3384-inoculated foetuses and the
mock-inoculated foetuses.
PCV1 isolation and titrations
High PCV1 titres were found in the lungs of the foe-
tuses S1R1 (104.7 TCID50/g tissue), S2R2 (10
4.6 TCID50/
g tissue) and S3R1 (102.9 TCID50/g tissue) inoculated
with the cell culture strain CCL33. All other organs of
CCL33-inoculated foetuses were negative (< 101.7
TCID50/g tissue) by virus titration. All collected organs
from the 3384-inoculated foetuses were negative (< 101.7
TCID50/g tissue) by virus titration. Mock-inoculated and
non-inoculated foetuses were negative for PCV1.
Single immunofluorescence staining
The number of PCV1-positive cells in the lungs of the
three CCL33-inoculated foetuses, i.e. S1R1, S2R2 and
S3R1, were 121, 31 and 28 cells/10 mm2, respectively
(Figure 1c.). A low number of PCV1-positive cells/10
mm2 was observed in the lungs of the three foetuses
inoculated with the field strain 3384 (4 (S1R4), 13
(S2R3) and 1 (S3R2) cells/10 mm2 respectively). PCV1-
positive cells were also observed in several other organs
such as spleen, liver (S1R1); spleen, liver and tonsils
(S2R2); and heart and thymus (S2R3) and the numbers
varied between 1 and 6 cells/10 mm2 of tissues (Table
2). PCV1-positive cells were not observed in the lungs
of the mock-inoculated and non-inoculated foetuses.
Double immunofluorescence staining (DIF)
The PCV1 antigens were mainly (97%) localized in the
epithelial cells of the lungs (Figure 2) of the PCV1-
inoculated foetuses. The other 3% of the PCV1 antigens
were localized in SWC3+ cells (cells of the monocytic
lineage) of the lungs (Figure 3). No co-localization of
PCV1 antigens was observed in endothelial cells, 41D3+
macrophages, B-lymphocytes and T-lymphocytes (data
not shown).
Amplification of PCV1 Rep gene and sequencing
In order to confirm that the foetuses had been inocu-
lated with the specific PCV1 strain and were not con-
taminated with PCV1 from neighbouring foetuses (as
mentioned in Table 1), a PCV1 Rep fragment was
amplified using heart and/or lung tissue from the
infected foetuses (21 days after inoculation) followed by
sequencing. PCR and DNA sequencing recovered
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CCL33 and 3384 sequences from CCL33- and 3384-
inoculated foetuses, respectively. No evidence for mixed
samples (e.g. containing more than one PCV1 strain) was
found. All the adjacent foetuses of PCV1-inoculated foe-
tuses were negative in PCR assays. All the mock-inocu-
lated foetuses and their adjacent foetuses were also
negative in PCR assays (Table 1). All the PCV1-inocu-
lated foetuses were also negative for PCV2 in PCR assays.
Serology
All the PCV1-inoculated foetuses had a very low anti-
PCV1 IPMA Ab titre of 10 to 40, except one foetus
(S2R2) inoculated with CCL33, which had a titre of 160.
The mock-inoculated and non-inoculated foetuses were
negative (< 10) for PCV1-specific IPMA Ab. All the
PCV1-inoculated and mock-inoculated foetuses were
negative (< 10) for PCV2-specific IPMA Ab.
Discussion
In this study, the virological and pathological outcomes
were examined in immuno-incompetent porcine foe-
tuses after inoculation with PCV1 at 55 days of
gestation.
The PCV1 cell culture strain CCL33 was found to be
pathogenic to porcine foetuses inoculated at 55-days of
foetal life. Severe haemorrhages were present in the
lungs of two out of three CCL33 inoculated foetuses.
These lesions correlated well with the highest PCV1
titres (104.7 TCID50/g and 10
4.6 TCID50/g) in the lungs.
The lungs with the lower level of virus replication (102.9
TCID50/g) did not have histopathological changes. Hae-
morrhages in the lungs can be explained by the fact that
due to the high PCV1 replication in the epithelial cells,
there might be the release of inflammatory mediators,
which may ultimately lead to the increased permeability
of the blood vessels followed by leakage of blood or hae-
morrhage. Under the conditions of the present study,
the PCV1 field strain 3384 was non-pathogenic to por-
cine foetuses. This suggests that a high PCV1 load could
be essential to induce pathology in porcine foetuses.
Several experimental studies had been performed in the
past to study the pathogenesis of PCV1 infections in 1-
day old, 2-days-old, 1 month old and 9 months old pigs
[8,9,14] but these experimental studies failed to repro-
duce disease in pigs. However, under the conditions of
the present study, it was demonstrated that PCV1 is
pathogenic for porcine foetuses. More research is
needed to determine the pathogenicity of PCV1.
Previously, Allan et al. [9] showed the distribution of
PCV1 antigens by virus isolation and IIF staining in
Figure 1 Different aspects of PCV1-CCL33 replication after inoculation of a 55-day old foetus. a) CCL33-inoculated foetus (S1R1) with a
normal external appearance. b) Haematoxylin and eosin staining of the lungs of a CCL33-inoculated foetus (S1R1). Haemorrhages (indicated by a
circle) in interlobular regions (magnification 10×). Bar = 200 μm. c) PCV1-positive cells in the lungs of CCL33-inoculated foetus (S1R1). Bar = 100
μm.
Table 2 Quantification of PCV1 positive cells in different foetal organs collected at 21 days post-PCV1 inoculation.
Strain Sow no. Inoculated foetusa Number of PCV1 positive cells/10 mm2 tissue
Heart Lungs Spleen Liver Kidney Thymus Tonsils Ileum Cerebrum
CCL33 S1 R1 - 121 6 4 - - - - -
CCL33 S2 R2 - 31 3 2 - - 1 - -
CCL33 S3 R1 - 28 - NA NA NA - - NA
3384 S1 R4 - 4 - - - - NA NA -
3384 S2 R3 4 13 - - - 3 - - -
3384 S3 R2 - 1 - - - - - NA -
a Foetuses were identified by their position in the uterus. R = right horn. Numbering is in sequence from ovary to cervix.
NA: not available; -: no positive cells detected
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Figure 2 Co-localization of PCV1 in the epithelial cells. Co-localization of PCV1 in the epithelial cells of the lungs of a CCL33-inoculated
foetus (Bar = 100 μm) and a 3384-inoculated foetus (Bar = 200 μm) collected at 21 days post inoculation (76 days of gestation). Methanol-fixed
cryostat sections were incubated (as described in Materials and Methods) with a cytokeratin marker monoclonal antibody AE1/AE3 to stain
epithelial cells (green fluorescence). Cells containing PCV1 antigens were localized using biotin-labelled mono-specific porcine anti-PCV1
polyclonal antibodies (red fluorescence).
Figure 3 Co-localization of PCV1 in monocytes (SWC3+ cells). Co-localization of PCV1 in monocytes (SWC3+ cells) of the lungs of a CCL33-
inoculated foetus (Bar = 100 μm) and a 3384-inoculated foetus (Bar = 100 μm) collected at 21 days post inoculation (76 days of gestation).
Methanol-fixed cryostat sections were incubated (as described in Materials and Methods) with a mAb anti-SWC3 (74.22.15) (green fluorescence).
Cells containing PCV1 antigens were localized using biotin-labelled mono-specific porcine anti-PCV1 polyclonal antibodies (red fluorescence).
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different organs of pigs, to be predominantly in the
lungs, although the level of PCV1 replication was not
quantitatively determined in that study. Our study
showed that the lung tissue was the main target organ
of replication of CCL33 strain, as this PCV1 strain could
only be isolated with high titres (up to 104.7 TCID50/g)
from the lungs. The field strain 3384 could not be iso-
lated from any of the inoculated foetuses, although they
were clearly PCR positive. These findings show that the
replication kinetics of the strains CCL33 and 3384 are
different from each other. Sequence comparison of the
Rep and capsid of CCL33 and 3384 revealed one synon-
ymous nucleotide substitution in the Rep and 4 amino
acid (aa) differences (at aa positions 69, 72, 74 and 116)
in the capsid protein (data not shown), suggesting that
these aa differences in the capsid protein could be
responsible for the different replication kinetics of these
two strains in porcine foetuses. Further research may
clarify this issue.
Single immunofluorescence staining revealed that
moderate (up to 121 cells/10 mm2 of tissues) and low
numbers (up to 13 cells/10 mm2) of PCV1 positive cells
were present in the lungs of the CCL33-inoculated and
the 3384-inoculated foetuses, respectively, although no
PCV1 could be isolated from the lungs of the 3384-
inoculated foetuses. Moreover, all the other organs of
the PCV1-inoculated foetuses were negative in virus iso-
lation, whereas PCV1 antigens were found at a low level
(up to 6 cells/10 mm2) in the heart, liver, spleen, thymus
and tonsils. These results suggest that immunostaining
of PCV1 is a more sensitive technique than virus isola-
tion and titration for the detection of PCV1. Compar-
ably, a previous study of McNeilly et al. [39] with PCV2
indicated that immunostaining of PCV2 is a more sensi-
tive technique than virus isolation for the detection of
PCV2 in porcine tissues.
The double staining of PCV1 and different cell mar-
kers established that the PCV1 antigens were mainly
localized in the lung epithelial cells and not in endothe-
lial cells, macrophages or lymphocytes of the lungs of
PCV1-inoculated foetuses. This is in contradiction with
previous observations in new-born piglets [9,16], where
it was shown that PCV1 is mainly present in non-
epithelial cells, morphologically resembling macro-
phages. It could be possible that the target cells for
PCV1 in foetal life might be different from the target
cells for PCV1 in newborn pigs, as previously shown for
PCV2 by Sanchez et al. [26]. PCV1 needs cellular DNA
polymerases of actively dividing cells to replicate [40]
and presumably epithelial cell types possess more mito-
tic activity in immuno-incompetent porcine foetuses
than in newborn pigs. The remaining 3% of the PCV1
antigens were localized in SWC3+ cells, which were
41D3-. It could be possible that due to high PCV1
replication in the lungs, there were newly infiltrating
monocytes (SWC3+, 41D3-). This study also indicates
that PCV1 and PCV2 have different cell tropism during
foetal life, since PCV2 replicates mainly in the cardio-
myocytes and macrophages of the heart tissue [26] and
PCV1 targets mainly the epithelial cells of the lungs.
In previous studies with PCV2 [20,21,41,42], it was
shown that PCV2 does not spread rapidly from one foe-
tus to another. Under the conditions of the present
study, no intrauterine spread of PCV1 from PCV1-
inoculated to non-inoculated foetuses was observed.
Immuno-competency in porcine foetuses develops at
around 80 days of gestation [43]. More specifically, por-
cine foetuses are able to mount a protective immune
response against small, non-enveloped, single-stranded
DNA viruses like PCV1, PCV2 or PPV when they are
infected after 70 days of gestation [20,21,44]. Foetuses
were inoculated with PCV1 strains at 55 days of foetal
life and their immune response to PCV1 was confirmed
by determining the PCV1-specific IPMA Ab titre. All
PCV1-inoculated foetuses developed very low anti-PCV1
antibody titres (10 to 40), except one foetus, which had
a titre of 160 that was inoculated with CCL33 strain.
Conclusions
From this study, it can be concluded that PCV1 can
replicate and may produce pathology in the lungs of
porcine foetuses inoculated at 55-days of foetal life.
More research is needed to confirm the pathogenic
character of PCV1 for porcine foetuses.
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